<b>Gapping up</b><br/><br/><b>In reaction to strong earnings/guidance:</b><br/>BLIN +17.5%, BB +7.3%, MU +7.1%, FDX +2%, GIS +0.2%.<br/>In Reaction to Strong MU earnings report:<br/>AMAT +2.2%, LRCX +2%, INTC +1%, NVDA +1%, WDC +0.9%, AMD +0.9%, STX +0.8%. <br/><b>Notable Crypto Plays:</b><br/>SSC +55.8%, LFIN +18.7%, FTFT +13.6%, XNET +8.0%, OTIV +7.5%, DPW +6.1%, GROW +4.3%, SRAX +3.8%, MARA +2.9%, RIOT +2.3%.<br/><b>Other news:</b><br/>SKLN +21.1% (to purchase an equity stake in Helomics Corporation),<br/>GSUM +13.9% (Launches AI-driven, Software as a Service, Intelligent CRM Solution for the China market),<br/>EXEL +5.3% (continued strength after FDA approval of CABOMETYX tablets for previously untreated advanced renal cell carcinoma),<br/>TIG +1.9% (Announces plans to focus its resources and capabilities on its eASC platform technology and its product candidates Cx601 and Cx611),<br/>BIIB +1.6% (Ionis Pharma and Biogen enter collaboration agreement to identify new antisense oligonucleotide drug candidates for the treatment of spinal muscular atrophy),<br/>AL +1.4% (slightly higher in after hours following upgrade to Buy at Buckingham ),<br/>UPS +0.8% (following FDX results). <br/><b>Analyst comments:</b><br/>QHC +5.4% (Upgraded to Equal-Weight from Underweight at Morgan Stanley),<br/>AKS +2.5% (Upgraded to Buy from Neutral at Longbow),<br/>X +2.1% (Upgraded to Buy from Neutral at Longbow),<br/>WEN +1.8% (Upgraded to Outperform from Neutral at Wedbush),<br/>WTW +1.6% (Initiated with a Buy at B. Riley FBR, Inc.; tgt $65),<br/>BIIB +1.6% (Upgraded to Outperform from Neutral at Credit Suisse),<br/>UAL +1.3% (Upgraded to Buy from Neutral at Buckingham Research),<br/>AA +1.1% (Upgraded to Outperform from Neutral at Credit Suisse),<br/>TS +1.1% (Initiated with a Overweight at Barclays; tgt $39),<br/>NUE +0.9% (Upgraded to Buy from Neutral at Longbow).<br/><br/><b>Gapping down</b><br/><br/><b>In reaction to disappointing earnings/guidance:</b><br/>SFIX -11.1%, RHT -2.0%, IBKC -1.8%.<br/><b>Notable Crypto Plays:</b><br/>CCIH -21.3%, MGTI -2.1%<br/><b>Other news:</b><br/>ROKA -46.3% (To delist from NASDAQ Global Markets),<br/>TXMD -8.8% (announces FDA acceptance of New Drug Application and PDUFA target action date of May 29, 2018 for TX-004HR),<br/>CBIO -2.6% (proposes public offering of common stock),<br/>STM -1.4% (Still Checking).<br/><b>Analyst comments:</b><br/>IBKC -1.8% (Downgraded to Outperform from Strong Buy at Raymond James),<br/>JACK -1.8% (Downgraded to Hold from Buy at Jefferies),<br/>CENX -1.7% (Downgraded to Hold from Buy at Deutsche Bank),<br/>SEP -1.1% (Downgraded to Equal Weight from Overweight at Barclays),<br/>HCA -1% (Downgraded to Underweight from Equal-Weight at Morgan Stanley),<br/>THC -0.9% (Downgraded to Underweight from Equal-Weight at Morgan Stanley),<br/>GILD -0.9% (Downgraded to Neutral from Outperform at Credit Suisse),<br/>GDS -0.9% (Downgraded to Neutral from Outperform at Credit Suisse)<br/><br/>Briefing.com